Emerald Health Therapeutics Inc.
Pure Sunfarms is a joint venture with vegetable producer Village Farms and it features a 1.1 million sq. ft. greenhouse in Delta, BC. Emerald said it has now been profitable for the last two quarters and it is now operating at full capacity.
“Pure Sunfarms’ growing operation is setting the standard for large-scale low cost high quality cannabis production, which we believe serves as a strong indication of what the combined expertise of Emerald and Village Farms can accomplish,” said Emerald executive chairman and president Avtar Dhillon.
He called Pure Sunfarms “a tremendously valuable asset” and said quality, yield, and production cost per gram have exceeded his initial goals.
Pure Sunfarms has supply deals in place with the Ontario Cannabis Store, the ecommerce store run by the province, along with other provincial, territorial, and private retailers. It expects to receive direct sales approval from Health Canada in the “near future”.
The joint venture facility is also pressing ahead with in-house extraction capabilities and that is expected to be operational this year. Edibles and other concentrates will be legalized in Canada by the end of 2019, opening up another revenue stream for Pure Sunfarms.
The plan now is to double the annualized production capacity to 150,000 kg by building out another greenhouse adjacent to its existing one. It will complete its first harvest at the new facility by mid-2020, and it expects to reach the 150,000 kg by 2021.
Yesterday, Emerald, which also has a wholly-owned facility in Quebec called Verdélite, announced that it expanded distribution of its SYNC 25 CBD oil to two more provinces. In May, it sold the Emerald-branded, Indica-dominant CBD oil to the British Columbia Liquor Distribution Branch, and it is now selling in Alberta and Saskatchewan too.
It shipped 9,960 40-ml units to Alberta Gaming, Liquor and Cannabis and Saskatchewan Liquor and Gaming Authority.
The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.